StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.82−0.17 (-8.42%)

Close on Nov 17, 2026Market cap $2.65MP/E –Yield –

Nexentis Technologies cash

Cash and short-term investments held at the end of each period.

Nexentis Technologies's cash was $8.88M at Jun 30, 2026. For fiscal 2025 it was $4.07M, up 61.8% from the year before. The highest annual figure on record is $6.75M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.07M+61.8%
FY2024Dec 31, 2024$2.52M-43.8%
FY2023Dec 31, 2023$4.48M-22.1%
FY2022Dec 31, 2022$5.75M-14.8%
FY2021Dec 31, 2021$6.75M+2679.3%
FY2020Dec 31, 2020$242.90K-16.5%
FY2019Dec 31, 2019$290.82K-33.9%
FY2018Dec 31, 2018$439.81K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.88M+158.6%
Q1 FY2026Mar 31, 2026$6.20M+108.3%
Q4 FY2025Dec 31, 2025$4.07M+61.8%
Q3 FY2025Sep 30, 2025$6.28M+126.6%
Q2 FY2025Jun 30, 2025$3.43M-23.5%
Q1 FY2025Mar 31, 2025$2.98M-15.3%
Q4 FY2024Dec 31, 2024$2.52M-43.8%
Q3 FY2024Sep 30, 2024$2.77M+40.0%
Q2 FY2024Jun 30, 2024$4.49M+48.8%
Q1 FY2024Mar 31, 2024$3.51M-23.6%
Q4 FY2023Dec 31, 2023$4.48M-22.1%
Q3 FY2023Sep 30, 2023$1.98M-70.4%
Q2 FY2023Jun 30, 2023$3.02M-31.1%
Q1 FY2023Mar 31, 2023$4.60M-18.6%
Q4 FY2022Dec 31, 2022$5.75M-14.8%
Q3 FY2022Sep 30, 2022$6.69M-13.9%
Q2 FY2022Jun 30, 2022$4.38M-52.9%
Q1 FY2022Mar 31, 2022$5.64M+1425.2%
Q4 FY2021Dec 31, 2021$6.75M+2679.3%
Q3 FY2021Sep 30, 2021$7.77M+2402.3%
Q2 FY2021Jun 30, 2021$9.31M+26298.7%
Q1 FY2021Mar 31, 2021$370.07K+105.6%
Q4 FY2020Dec 31, 2020$242.90K-16.5%
Q3 FY2020Sep 30, 2020$310.57K-29.4%
Q2 FY2020Jun 30, 2020$35.25K–
Q1 FY2020Mar 31, 2020$180.00K–
Q4 FY2019Dec 31, 2019$290.82K–
Q4 FY2018Dec 31, 2018$439.81K–

More Nexentis Technologies figures

See a number that looks wrong?